Your browser doesn't support javascript.
loading
External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma.
Yip, Pui-Lam; Lee, Shing-Fung; Choi, Cheuk-Wai Horace; Chan, Po-Chung Sunny; Cheung, Ka-Wai Alice; Chow, Chung-Hang James; Cheung, Ka-Man; Lai, Wing-Yu Jessica; Lee, Ho-Fun Victor; Lam, Ka-On; Chiang, Chi-Leung; Wong, Chun-Yin Edwin; Poon, Ming-Chun Darren; Tong, Macy; Au, Kwok-Hung; Ng, Wai-Tong; Ngan, Kai-Cheong Roger; Lee, Wing-Mui Anne; Tung, Yuk Stewart.
Afiliação
  • Yip PL; Department of Clinical Oncology, Tuen Mun Hospital, Hospital Authority, Hong Kong, China.
  • Lee SF; Department of Clinical Oncology, Tuen Mun Hospital, Hospital Authority, Hong Kong, China.
  • Choi CH; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Chan PS; Department of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Hong Kong, China.
  • Cheung KA; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Chow CJ; School of Public Health, Li Ka Shing School of Public Health, The University of Hong Kong, Hong Kong, China.
  • Cheung KM; Department of Clinical Oncology, Tuen Mun Hospital, Hospital Authority, Hong Kong, China.
  • Lai WJ; Department of Clinical Oncology, Tuen Mun Hospital, Hospital Authority, Hong Kong, China.
  • Lee HV; Department of Clinical Oncology, Queen Elizabeth Hospital, Hospital Authority, Hong Kong, China.
  • Lam KO; Department of Clinical Oncology, Queen Elizabeth Hospital, Hospital Authority, Hong Kong, China.
  • Chiang CL; Department of Oncology, Princess Margaret Hospital, Hospital Authority, Hong Kong, China.
  • Wong CE; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Poon MD; Department of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Hong Kong, China.
  • Tong M; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Au KH; Department of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Hong Kong, China.
  • Ng WT; Department of Clinical Oncology, Tuen Mun Hospital, Hospital Authority, Hong Kong, China.
  • Ngan KR; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Lee WA; Department of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Hong Kong, China.
  • Tung YS; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hospital Authority, Hong Kong, China.
Cancers (Basel) ; 13(17)2021 Aug 25.
Article em En | MEDLINE | ID: mdl-34503096
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article